Zimhi Injection, Solution
Product Images NDC 84571-140

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Zimhi (NDC 84571-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zmi Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Do Not Attempt To Reuse Zimhi. Each Zimhi Contains A Single-dose Of Naloxone Hydrochloride For Single-dose Injection. (Zimhi 01)

An instructional diagram of the ZIMHI injection solution showing labeled components of the prefilled syringe: removable needle cap, safety guard, syringe barrel, solution window, plunger, and a visual indication to insert the needle into the thigh for administration.*

FDA Label Image

Embed The Needle Completely Before Transferring The Thumb To The Syringe Plunger. (Zimhi 02)

Illustration showing the administration of an injection into the thigh area. One hand pinches the skin while the other holds a syringe, demonstrating intramuscular or subcutaneous injection technique on the upper leg.*

FDA Label Image

Immediately After Injection, Using One Hand With Fingers Behind The Needle, Slide The Safety Guard Over The Needle. Do Not Use Two Hands To Activate The Safety Guard. (Zimhi 03)

An instructional illustration showing a hand holding a syringe with a labeled Safety Guard. The image highlights the Safety Guard component of the injection device, emphasizing proper handling.*

FDA Label Image

Structural Formula For Naloxone Hydrochloride (Zimhi 04)

Chemical structure of Naloxone Hydrochloride, showing the molecular framework with hydroxyl groups, a cyclohexane ring, and associated hydrochloride indicated in the diagram.*

FDA Label Image

Figure 1 Mean ± Sd Plasma Concentration Of Naloxone, (a) 0-30 Min And (b) 0-12 H Following A Single Intramuscular Administration Of 5 mg Zimhi And A Single Intramuscular Administration Of 2 mg Naloxo (Zimhi 05)

A line graph comparing plasma concentration of naloxone over 30 minutes post-dose between ZIMHI 5 mg IM injection (5 mg/0.5 mL) and a 2 mg IM injection (2 mg/2 mL). The y-axis represents naloxone plasma concentration in ng/mL, and the x-axis represents time in minutes post-dose. ZIMHI shows higher plasma concentrations throughout.*

FDA Label Image

Mean ± Sd Plasma Concentration Of Naloxone, (a) 0-1 H And (b) 0-12 H Following Intramuscular/subcutaneous Administration Using Zimhitm (Zimhi 06)

A pharmacokinetic graph displaying naloxone plasma concentration (ng/mL) over time (hours post dose) for ZIMHI 5 mg intramuscular injection compared to a 2 mg intramuscular injection. The graph shows concentration declining over 12 hours with error bars indicating variability at each time point.*

FDA Label Image

Zimhitm Works Like A Standard Prefilled Syringe. (Zimhi 07)

An illustration of a syringe with a plunger and needle, shown filled with a dark liquid, representing an injection device. The image does not include any text or labeling.*

FDA Label Image

Zimhitm Is Injected Downwards, Into The Thigh, (as Shown), Through Clothing If Necessary. (Zimhi 08)

An instructional illustration showing an injection being administered into the upper thigh muscle. The image highlights the intramuscular injection site with a red oval on the thigh, demonstrating the proper location for delivering an intramuscular or subcutaneous injection.*

FDA Label Image

Ready To Use Zimhitm (Zimhi 09)

FDA Label Image

When Ready To Inject, Pull Off Cap To Expose Needle. (Zimhi 0a)

The image shows the front of a ZIMHI injection carton. It is a human prescription drug containing Naloxone Hydrochloride at a strength of 5 mg per 0.5 mL. The dosage form is solution for intramuscular or subcutaneous injection. The labeler is ZMI Pharma Inc.*

FDA Label Image

Hold Zimhi By Finger Grips Only And Slowly Insert The Needle Into The Thigh. (Zimhi 0b)

An instructional diagram of a prefilled injection syringe labeled with steps and parts, including the removable needle cap, safety guard, syringe barrel, solution window, plunger, and guidance to insert the needle into the thigh and pull off the cap. The diagram illustrates correct administration technique for an injection device.*

FDA Label Image

Number 3 (Zimhi 0c)

FDA Label Image

After Needle Is In Thigh: Push The Plunger All The Way Down Until It Clicks And Hold For 2 Seconds. (Zimhi 0d)

An instructional illustration showing the top portion of a vial with a cap labeled '3,' accompanied by a downward red arrow above the cap indicating the action of pressing or removing the cap.*

FDA Label Image

Number 4 (Zimhi 0e)

FDA Label Image

Right After The Injection, Using One Hand With Fingers Behind The Needle, Slide The Safety Guard Over The Needle. Do Not Use Two Hands To Activate The Safety Guard. Put The Used Syringe Into The Blue (Zimhi 0f)

An instructional illustration showing a hand holding an injection device with a pointed tip covered by a 'Safety Guard.' The image highlights the removal or presence of the safety guard on the needle or injection tip, implying steps for safe handling or preparation of a parenteral injection device.*

FDA Label Image

Number 5 (Zimhi 10)

ZIMHI 5 mg/.5 mL injection, solution label showing the numeric strength "5" inside a purple hexagon. The labeling is consistent with a medication for intramuscular or subcutaneous use, distributed by ZMI Pharma Inc.*

FDA Label Image

Get Emergency Medical Help Now (Zimhi 11)

FDA Label Image

Turn The Patient On Their Side (recovery Position) After Giving Zimhi. (Zimhi 12)

An illustration of a person lying on their side with one leg bent, demonstrating the recovery position used to maintain an open airway and prevent aspiration.*

FDA Label Image

Use Second Syringe If Necessary (Zimhi 13)

A black and white line drawing illustrating two syringes or injection devices side by side, both featuring measurement markings and a capped needle end, likely representing the administration method for an injectable medication.*

FDA Label Image

Ndc 84571-140-02rx Onlyzimhitm(naloxone HCl Injection, Usp)5 mg/ 0.5 mL (Zimhi 14)

Box packaging label for ZIMHI (naloxone HCl Injection, USP) 5 mg/0.5 mL. The label indicates the product is for intramuscular or subcutaneous injection and used for opioid emergencies. The box contains two 5 mg prefilled single-dose syringes. Labeler is ZMI Pharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.